Top Markets
Coin of the day
Petros Pharmaceuticals, Inc. Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

PTPI
Rank in Stocks #40525
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male... Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Share Price
$0.0034
Market Cap
$144.07K
Change (1 day)
13.33%
Change (1 year)
-88.67%
Country
US
Trade Petros Pharmaceuticals, Inc. (PTPI)

Category

Stock price history for Petros Pharmaceuticals, Inc. (PTPI)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $940.79 on 2020-12-01
Stock price history of Petros Pharmaceuticals, Inc. from 2020 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 20.28%
2025 -99.87%
2024 -75.80%
2023 -45.66%
2022 -91.72%
2021 -18.19%
2020 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$165.47 27.27%
DE
$36.27 22.59%
JP
$232.21 43.17%
CH
$21.32 13.71%
IN